Arcelus J I, Caprini J A, Hoffman K N, Fink N, Size G P, Fareed J, Hoppensteadt D
Department of Surgery, Glenbrook Hospital, Glenview, IL 60025, USA.
J Vasc Surg. 1996 Apr;23(4):616-21. doi: 10.1016/s0741-5214(96)80041-3.
The purpose of this article was to assess a number of hematologic and fibrinolytic assays at the time of diagnosis of deep vein thrombosis (DVT) and at several intervals over a period of 6 months afterward and to correlate these results with the results of serial duplex scanning.
Thirty-five patients (average age 61, range 18 to 82) with acute symptomatic DVT confirmed by duplex scanning were included. On diagnosis, blood was drawn, and plasma levels of tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor (PAI), D-dimer (DD), and tissue factor pathway inhibitor (TFPI) were determined. Duplex scanning and all laboratory assays were repeated 1 week, 1 month, 3 months, and 6 months thereafter.
The rate of DVT complete resolution 6 months after diagnosis was 57%. Whereas plasma levels of PAI were similar throughout the 6-month follow-up period, t-PA increased significantly 1 week after diagnosis and decreased thereafter. Both DD and TFPI levels decreased significantly after diagnosis compared with presentation values. Comparing these assay levels between patients with complete resolution versus partial or no resolution, PAI levels were significantly higher during the first week in patients with poor outcome. Plasma levels of t-PA were higher in cases with good outcome, and DD levels were higher in patients with poor outcome. TFPI levels were similar in both outcome groups.
Patients with complete DVT resolution on duplex scanning at 6 months had significantly lower levels of PAI on presentation and after 1 week than did those with incomplete lysis. Although differences were not significant, t-PA levels were higher and DD lower in patients with good outcome. Our results suggest that certain plasma fibrinolytic assays might correlate with the outcome of DVT, as assessed by duplex ultrasonography.
本文旨在评估深静脉血栓形成(DVT)诊断时及之后6个月内多个时间点的多项血液学和纤维蛋白溶解检测指标,并将这些结果与系列双功超声扫描结果进行关联。
纳入35例经双功超声扫描确诊为急性症状性DVT的患者(平均年龄61岁,范围18至82岁)。诊断时采集血液,测定血浆组织型纤溶酶原激活剂(t-PA)、纤溶酶原激活剂抑制剂(PAI)、D-二聚体(DD)和组织因子途径抑制剂(TFPI)水平。此后1周、1个月、3个月和6个月重复进行双功超声扫描和所有实验室检测。
诊断后6个月DVT完全溶解率为57%。在6个月的随访期内,PAI的血浆水平相似,而t-PA在诊断后1周显著升高,之后下降。与就诊时相比,诊断后DD和TFPI水平均显著下降。比较完全溶解与部分溶解或未溶解患者的这些检测指标水平,预后不良患者在第一周的PAI水平显著更高。预后良好的病例中t-PA的血浆水平更高,预后不良的患者中DD水平更高。两组预后患者的TFPI水平相似。
在6个月时双功超声扫描显示DVT完全溶解的患者,就诊时和1周后的PAI水平明显低于溶解不完全的患者。虽然差异不显著,但预后良好的患者t-PA水平较高,DD水平较低。我们的结果表明,某些血浆纤维蛋白溶解检测指标可能与双功超声评估的DVT预后相关。